Elypta raises $21 million Elypta, part of the Accelerator at Sahlgrenska Science Park, raises $21 million Series A to develop metabolism-based multi-cancer early detection test.
Daring to share innovations across the Nordics Within health innovations we see many similarities in the Nordics in scaling business to shape a brighter future.
Premium test facilities - Nordic Proof The Accelerator is in a new collaboration aiming to catalyse testbed possibilities for West Swedish startups and scaleups when partnering up with Nordic Proof.
VIDEM raises 5 MSEK for pioneering infectious disease diagnostics PCR tests have cost the Swedish government SEK 22 billion throughout the pandemic. A new method will enable cheaper, faster and more accu...
Making magic on Medicine Hill Two of the four successful startup companies to join the MobilityXlab open collaboration platform in the latest round of applications are...
Cuviva a force in transforming the healthcare system Cuviva's solution enables new ways of working in healthcare – the result is increased quality of care and reduced total costs
